Sell-Side Rating Spotlight on Shares of Medpace Holdings, Inc. (:MEDP)

Sell-side analysts often undertake stock analysis to give their opinions of whether they believe that shares should be bought, sold, or held. Using ratings provided by analysts to Zacks Research, we can see that the current average broker rating on shares of Medpace Holdings, Inc. (:MEDP) is currently 2.33. This consensus rating uses a number scale from 1 to 5. A low number between 1 and 2 indicates a Buy or Strong Buy.  A 3 rating would represent a Hold, while a 4 or 5 indicates a Sell rating. After a recent check, we can see that 2 sell-side analysts have rated the stock a Strong Buy or Buy, based analysts polled by Zacks Research.

When the stock market starts to get volatile, investors might start getting worried about their investments. The natural response is to do something about it and take some action. Sometimes this may be necessary, but sometimes the best way to deal with volatility may be to wait it out and stay the course. It can be scary to watch the portfolio decline, and nobody wants to see their stocks taking a nosedive. Although there is no foolproof strategy to ride out market downturns, investors often agree that having a diversified stock portfolio may be the most logical defense.

Sell-side Wall Street analysts will commonly offer stock price target estimates. Many investors pay close attention to where the analysts project the stock moving in the future. After a recent scan, we can see that analysts polled by Zacks Research have set a consensus price target of $58.25 on shares of Medpace Holdings, Inc. (:MEDP). Price target estimates can be calculated using various methods, and they may be quite different depending on the individual analyst. A fully researched analyst report will generally provide detailed reasoning for a specific target price prediction. Some investors may track analyst targets very closely and use the information to complement their own stock research.

Taking a quick look at the current quarter EPS consensus estimate for Medpace Holdings, Inc. (:MEDP), we can see that the most recent level is sitting at 0.6. This EPS projection uses 6 Sell-Side analysts polled by Zacks Research. For the previous reported quarter, the company posted a quarterly EPS of 0.76. Covering analysts have the tough job of following companies and offering future estimates. These estimates are often closely followed on the Street, and earnings beats or misses revolve around these projections. Sometimes these predictions are extremely close to the actual reported number, and other times they may be way off. When a company posts actual earnings numbers, the surprise factor can lead to sudden stock price fluctuations. If a company meets and beats estimates and posts a positive earnings surprise, the stock may see a near-term bump. On the other end, a negative surprise may send the stock in the opposite direction. Many investors will choose to trade with caution around earnings releases and wait to make a move until after the major activity has subsided.

Zooming in on recent stock price action for Medpace Holdings, Inc. (:MEDP), we note that shares are trading near the 57.66 level. Investors will often follow stock price levels in relation to the 52-week high and low levels. The 52-week high is presently 70.58, and the 52-week low is sitting at 34.03. When a stock price is getting close to either the 52-week high or 52-week low, investors may track activity to watch for a move past the established mark. Over the last 12 weeks, shares have seen a change of 8.94%. Heading further back to the start of the year, we note that shares have seen a change of 8.94%. Focusing in closer to the last 4 weeks, shares have seen a change of 4.67%. Over the past five trading days, the stock has changed 1.5%.

Investors may be looking ahead to the next round of company earnings reports. Following the numbers may assist investors when attempting to do stock research. Many investors will closely follow the results to see how far off they are from the most recent analyst estimates. Analysts may be busy updating estimates before and after company earnings reports. Investors have the option of following analyst projections in order to help gauge how the sell-side is viewing company prospects. Many investors will also choose to follow analyst buy, sell, and price target recommendations.